Immunogenicity 15700

summary
Sample ID
L012
Response
Positive
Tumor Type
NSC Lung cancer
Gene Symbol
MYADM
Transcript ID
None
HLA INFO
B*07:02
TCR INFO

No TCR info found!

T cell Tumor cell B*07:02
sequence
Full length protein sequence (322 aa)
MPVTV
1
TRTTI
6
TTTTT
11
SSSGL
16
GSPMI
21
VGSPR
26
ALTQP
31
LGLLR
36
LLQLV
41
STCVA
46
FSLVA
51
SVGAW
56
TGSMG
61
NWSMF
66
TWCFC
71
FSVTL
76
IILIV
81
ELCGL
86
QARFP
91
LSWRN
96
FPITF
101
ACYAA
106
LFCLS
111
ASIIY
116
PTTYV
121
QFLSH
126
GRSRD
131
HAIAA
136
TFFSC
141
IACVA
146
YATEV
151
AWTRA
156
RPGEI
161
TGYMA
166
TVPGL
171
LKVLE
176
TFVAC
181
IIFAF
186
ISDPN
191
LYQHQ
196
PALEW
201
CVAVY
206
AICFI
211
LAAIA
216
ILLNL
221
GECTN
226
VLPIP
231
FPSFL
236
SGLAL
241
LSVLL
246
YATAL
251
VLWPL
256
YQFDE
261
KYGGQ
266
PRRSR
271
DVSCS
276
RSHAY
281
YVCAW
286
DRRLA
291
VAILT
296
AINLL
301
AYVAD
306
LVHSA
311
HLVFV
316
KV
321
Mutation Information
DNA mutation:
None
Peptide Range:
22 ~ 30
Mut AA position:
None (9 in Wild Type peptide)
Alignment
Wild Type:
"SPMIVGSPR
||||||||.
Mutant:
SPMIVGSPW"
reference
clinic trial
Checkpoint Blockade

pembrolizumab

ACT

N

Vaccination

N

Curative Effect

clinical benefit

experiment
minimal_peptide

Y

Antigen Type

multimer

T-cell Source

PBMCs

APC Type

None

Assay

None